GetTopicDetailResponse(id=cf511242866b, topicName=catumaxomab, introduction=, content=catumaxomab 惡性腹水, image=null, comments=0, allHits=219, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Feb 16 15:38:29 CST 2025, time=2025-02-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=105039, tagList=[TagDto(tagId=105039, tagName=catumaxomab)], ipAttribution=威斯康星, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2252194, encodeId=ae7b22521944d, content=<a href='/topic/show?id=cf511242866b' target=_blank style='color:#2F92EE;'>#catumaxomab#</a> <a href='/topic/show?id=1298110548bd' target=_blank style='color:#2F92EE;'>#惡性腹水#</a>, objectTitle=CD3xEpCAM雙抗卡妥索單抗歐盟獲批上市！用于治療癌性惡性腹水！, objectType=article, longId=863583, objectId=017b86358391, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20241101/9e8efe9886664612a15d3e1699d1e476-e6MWC18jovxB.jpg, objectUrl=/article/show_article.do?id=017b86358391, replyNumber=0, likeNumber=30, createdTime=2025-02-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=017b86358391, moduleTitle=CD3xEpCAM雙抗卡妥索單抗歐盟獲批上市！用于治療癌性惡性腹水！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=017b86358391)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-16發(fā)表于威斯康星
